Lorazepam Tablet
Product Images NDC 71610-225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 0.5 mg (71610 0225 15)

Bottle Label 0.5 mg (71610 0225 15)
Label for Lorazepam 0.5 mg oral tablets by Aphena Pharma Solutions - Tennessee, LLC. The label includes storage instructions between 20-25 degrees Celsius, dispensing in a tight, light-resistant container, and warns that the drug may be habit-forming. Package size is 15 tablets, labeled for prescription use only, with manufacturing and expiration dates visible.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Lorazepam Structure (Lorazepam Structure)
Chemical structure of Lorazepam, showing its molecular formula C15H10Cl2N2O2 and molecular weight 321.16. The diagram includes two chlorinated benzene rings and other characteristic molecular bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.